CARCELL BIOPHARMA
Carcell Biopharma is a pre-clinical biotech company. Carcell Biopharma develops cell and gene therapy products with an innovative cross-border business model.
CARCELL BIOPHARMA
Social Links:
Industry:
Biotechnology Genetics Health Care Medical
Founded:
2017-01-01
Total Employee:
1+
Status:
Active
Total Funding:
100 M CNY
Current Employees Featured
Founder
Investors List
BioTrack Capital
BioTrack Capital investment in Seed Round - Carcell Biopharma
Hyfinity Investments
Hyfinity Investments investment in Seed Round - Carcell Biopharma
Legend Star
Legend Star investment in Seed Round - Carcell Biopharma
More informations about "Carcell Biopharma"
Carcell Biopharma - Crunchbase Company Profile & Funding
Organization. Carcell Biopharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Carcell Biopharma is a pre-clinical …See details»
Carcell Biopharma - LinkedIn
Carcell Biopharma ("Carcell") is a global biotech company launched by EVX Ventures. With an innovative “hub-and-spoke” business model, Carcell accelerates innovations in and translation of ...See details»
Carcell Biopharma | Powertrain Platform: From …
Carcell's Powertrain Platform has two lead technological platforms: (1) Our E3 platform produces exciting red cell therapies to treat autoimmune disorders; (2) We apply high throughput screening philosophies to discover novel and potent …See details»
Company | Carcell
© 2024 Carcell Biopharma. All Rights Reserved. an. CompanySee details»
Carcell Biopharma - Funding, Financials, Valuation & Investors
Carcell Biopharma is a pre-clinical biotech company that promotes the development of next-generation cell and gene therapies. Search Crunchbase. Start Free Trial . ... How much …See details»
Carcell Biopharma - Products, Competitors, Financials, Employees ...
Carcell Biopharma is a company focused on the development and translation of next-generation cell and gene therapies in the biopharmaceutical industry. Use the CB Insights Platform to …See details»
Carcell Biopharma - VentureRadar
Carcell Biopharma specializes in the development of innovative cell and gene therapies. Utilizing their proprietary 'Powertrain' platform, they focus on accelerating the development process …See details»
Carcell BioPharma - PitchBook
Carcell BioPharma General Information Description. Developer of biopharmaceutical platforms intended to promote next-generation cell and gene therapies. The company's platforms focus …See details»
Carcell Biopharma closes an oversubscribed financing …
Advancing the next generation of cell and gene therapies via a "platform of platforms" modelSINGAPORE, Nov. 1, 2021 -- Carcell Biopharma ("Carcell", the "Company") announced today the close of an over-subscribed financing. The …See details»
Carcell welcomes Prof. Harvey Lodish as Chair of its …
Dec 19, 2022 SINGAPORE and SHANGHAI, Dec. 19, 2022 /PRNewswire/ -- Carcell Biopharma ("Carcell"), an EVX Ventures company, is pleased to announce Prof. Harvey Lodish as the Chair of the Scientific Advisory Board.See details»
Carcell Biopharma closes an oversubscribed financing round led …
Nov 2, 2021 /CNW/ -- Carcell Biopharma ("Carcell", the "Company") announced today the close of an over-subscribed financing. ... Organization Profile. Carcell Biopharma Inc. Contact …See details»
Carcell Biopharma - LinkedIn
Carcell Biopharma | 998 followers on LinkedIn. Developing next-generation cell and gene therapies | Carcell Biopharma ("Carcell") is a global biotech company launched by …See details»
Carcell and CATUG enter into a strategic partnership for lipid ...
Jan 16, 2024 Carcell Biopharma is a pre-clinical biotech company launched by EVX Ventures. Carcell was founded in 2021 by a team of serial entrepreneurs and seasoned biopharma …See details»
Carcell welcomes Prof. Harvey Lodish as Chair of its Scientific ...
Dec 20, 2022 SINGAPORE and SHANGHAI, Dec. 19, 2022 -- Carcell Biopharma ("Carcell"), an EVX Ventures company, is pleased to announce Prof. Harvey Lodish as the Chair of the …See details»
Carcell Biopharma closes an oversubscribed financing round led …
SINGAPORE, Nov. 2, 2021 /PRNewswire/ -- Carcell Biopharma ("Carcell", the "Company") announced today the close of an over-subscribed financing. The round was led by Hyfinity …See details»
Carcell Biopharma closes an oversubscribed financing round led …
Nov 2, 2021 Advancing the next generation of cell and gene therapies via a “platform of platforms” modelSINGAPORE, Nov. 1, 2021 /PRNewswire/ -- Carcell Biopharma ("Carcell", …See details»
Carcell Biopharma closes an oversubscribed financing round led …
Nov 2, 2021 Carcell Biopharma is a pre-clinical biotech company incubated by EVX Ventures. Following a "platform of platforms" model, Carcell's vision is to house multiple platform …See details»
Carcell welcomes Prof. Harvey Lodish as Chair of its Scientific ...
Dec 19, 2022 SINGAPORE and SHANGHAI, Dec. 19, 2022 /CNW/ -- Carcell Biopharma ("Carcell"), an EVX Ventures company, is pleased to announce Prof. Harvey Lodish as the …See details»
Carcell Biopharma | Latest News: From Singapore, Shanghai and …
Carcell Biopharma closes an oversubscribed financing round led by Hyfinity Investments Advancing the next generation of cell and gene therapies via a "platform of platforms" model …See details»